|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/573 | |
| A61K 31/58 | |||
| C12Q 1/6883 | |||
| C12Q 1/6886 |
| (11) | Patento numeris | 3143156 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15723409.7 |
| Europos patento paraiškos padavimo data | 2015-05-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-03-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/029627 |
| Data | 2015-05-07 |
| (87) | Numeris | WO 2015/175305 |
| Data | 2015-11-19 |
| (30) | Numeris | Data | Šalis |
| 201461991710 P | 2014-05-12 | US |
| (72) |
SOKOL RICCI, Deborah, US
LI, Weimin, US
GORMLEY, Michael, US
KARKERA, Jayaprakash, US
SCHAFFER, Michael, US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH ABIRATERONE ACETATE |
| BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH ABIRATERONE ACETATE |